by [email protected] | May 15, 2019 | Cancer (blood), Cancer (solid tumor), Publication
Abstract Authors: Wang L, Baser O, Kutikova L, Page JH, Barron R Purpose: The study aims to assess the relative efficacy of granulocyte colony-stimulating factor (G-CSF) products administered as primary prophylaxis (PP) to patients with cancer receiving...
by [email protected] | May 13, 2019 | Cancer (solid tumor), Publication
Abstract Authors: Bui CN, Wang L, Baser O. Objectives: Corticosteroids (CSs) are used concomitantly with life-extending therapies (LETs) in patients with castration-resistant prostate cancer (CRPC). This study examined time to LETs, LETs and concomitant CS...
by [email protected] | May 12, 2019 | Cancer (blood), Cancer (solid tumor), Publication
Abstract Authors: Wang L, Barron R, Baser O, Langeberg WJ, Dale DC Background: The Veterans Health Administration (VHA) is the largest integrated health care system in the United States and a major cancer care provider. Objective: To use VHA database to conduct a...
by [email protected] | May 10, 2019 | Cancer (solid tumor), Publication
Abstract Authors: Baser O, Wei W, Henk HJ, Teitelbaum A, Xie L. Objective: Triple-negative breast cancer (TNBC) is a high-grade breast cancer with an aggressive clinical course. We examined the recurrence rate, health care utilization, and cost of early-stage TNBC in...
by [email protected] | May 8, 2019 | Cancer (solid tumor), Publication
Abstract Authors: Baser O, Wei W, Henk HJ, Teitelbaum A, Xie L. Background: Triple-negative breast cancer (TNBC) makes up 10-17% of all breast cancers and, due to lack of receptor expression, is unresponsive to therapies that target hormonal receptors or HER2....
by [email protected] | May 6, 2019 | Cancer (solid tumor), Publication
Abstract Authors: Baser O, Wei W, Xie L, Henk HJ, Teitelbaum A. Background: Triple-negative breast cancer (TNBC) is a subset of breast cancer. Health care cost and utilization data for TNBC are lacking. Objective: We examined differences between metastatic TNBC and...
